Trials / Completed
CompletedNCT01706744
Effect of Discharge Via an Intermediate Care Unit
Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 328 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 60 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The main goal is to investigate the following topics: 1. Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital? 2. Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital? 3. Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intermediate care unit | |
| OTHER | Local health care 1 | |
| OTHER | Local health care 2 |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-10-15
- Last updated
- 2015-12-08
Locations
4 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT01706744. Inclusion in this directory is not an endorsement.